Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Heron Therapeutics, Inc.

NASDAQ: HRTX · Life Sciences · 4 alerts · CIK 818033

Share price
$0.2843Close, Nov 16
Market cap
$54.1M
Shares outstanding
190.27MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Heron Therapeutics, Inc. filings on SEC EDGAR ↗

5:00 PM ET 8-K
Licensing Deal

Heron Therapeutics Licensing Deal with Long Grove Pharmaceuticals, LLC

Heron Therapeutics entered into a multi-product Development and License Agreement with Long Grove Pharmaceuticals and Capstone Development Services. The agreement grants Heron an exclusive license to import, distribute, and market certain products in the U.S. in exchange for regulatory milestones, sales-based milestones, and royalty payments.

Counterparty
Long Grove Pharmaceuticals, LLC
Term
10 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.